Neila Smith Selected Research

conivaptan (Vaprisol)

1/2009	Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia.
7/2008	Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study.
3/2007	Intravenous conivaptan: effects on the QTc interval and other electrocardiographic parameters in healthy volunteers.
1/2007	Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
6/2006	Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neila Smith Research Topics

Disease

4	Overactive Urinary Bladder (Overactive Bladder) 12/2009 - 11/2006
4	Hyponatremia 01/2009 - 06/2006
2	Type 2 Diabetes Mellitus (MODY) 12/2018 - 01/2018
2	Constipation 12/2009 - 11/2006
2	Heart Failure 01/2009 - 03/2007
2	Injection Site Reaction 07/2008 - 01/2007
2	Nocturia 03/2007 - 11/2006
2	Urge Urinary Incontinence (Urge Incontinence) 03/2007 - 11/2006
1	Gastroesophageal Reflux (GERD) 01/2022
1	Infections 01/2022
1	Esophagitis 01/2022
1	Wounds and Injuries (Trauma) 01/2018
1	Liver Failure 01/2018
1	Dehydration (Water Stress) 12/2009
1	Cellulitis 12/2009
1	Chest Pain (Chest Pains) 12/2009
1	Anemia 01/2009
1	Hypotension (Low Blood Pressure) 01/2009
1	Fever (Fevers) 01/2009
1	Hypokalemia 01/2009
1	Urinary Tract Infections (Urinary Tract Infection) 01/2009
1	Dyspepsia (Indigestion) 11/2006
1	Headache (Headaches) 11/2006
1	Dry Eye Syndromes (Dry Eye Syndrome) 11/2006
1	Nausea 11/2006

Drug/Important Bio-Agent (IBA)

5	conivaptan (Vaprisol)FDA Link 01/2009 - 06/2006
4	Solifenacin Succinate FDA Link 12/2009 - 11/2006
3	Arginine Vasopressin (Argipressin)IBA 01/2009 - 01/2007
3	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2009 - 01/2007
2	TAK-875IBA 12/2018 - 01/2018
2	Cholinergic Antagonists (Anticholinergics)IBA 12/2009 - 11/2006
2	Antidiuretic Hormone Receptor AntagonistsIBA 01/2009 - 06/2006
2	SodiumIBA 01/2007 - 06/2006
2	Vasopressins (Vasopressin)IBA 01/2007 - 06/2006
1	AcidsIBA 01/2022
1	PotassiumIBA 01/2022
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Muscarinic AntagonistsIBA 12/2009
1	Pharmaceutical PreparationsIBA 12/2009
1	ElectrolytesIBA 06/2006

Therapy/Procedure

1	Intravenous Infusions 01/2007